It was further revealed that 17β-estradiol not only stimulates the expression of SREBP1 but also promotes its maturation into the active nuclear form, connecting estrogen signaling with lipid metabolic reprogramming in ER+ breast cancer [66]. Here, SREBF1 is linked to breast cancer.